As many as 91 countries are likely to be affected by India’s decision to ban exports of vaccines like Serum Institute of India’s (SII) products, including the AstraZeneca vaccine (Covishield) and the forthcoming Novavax, reports the World Health Organization (WHO). Inadequate vaccine stocks in these countries including Africa means they will be extremely susceptible to …

The post 91 countries face new strains as India bans vaccine export: WHO appeared first on The Filipino Times.